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Abstract
From among a plethora of various gene delivery methods, the researcher must choose the right
one according to availability for a given species and the precise application the transgenic animal is
intended for. Here we review the progress in meganuclease and Sleeping Beauty transposon
mediated transgenesis over recent years with a focus on medaka and zebrafish. We present a
side-by-side comparison of these two approaches based on their biologic properties and provide
interesting perspectives for future experiments and applications, which are different for the two
techniques because of their distinct modes of action.
Published: 31 October 2007
Genome Biology 2007, 8(Suppl 1):S10 (doi:10.1186/gb-2007-8-S1-S10)
The electronic version of this article is the complete one and can be
found online at http://genomebiology.com/2007/8/S1/S10
© 2007 BioMed Central Ltd 
Introduction
Transgenesis, the introduction of transgenes into the genome
of an organism and its appropriate expression in subsequent
generations, represents one of the major technologic ad-
vances in modern biology. Ectopic expression of transgenes
(gain of function) and disruption of endogenous genes (loss
of function) in transgenic animals have proven to be highly
valuable in extending our knowledge of mechanisms of
development and developmental gene regulation, the action
of oncogenes, and intricate cell interactions within the
immune and nervous systems. By employing reporter genes
under the control of specific regulatory sequences, transgenic
techniques allow functional dissection of cis-acting elements
that are responsible for spatial and temporal gene expression
patterns. In addition, tissues or cells that express a reporter
transgene can be used in cell lineage analysis and trans-
plantation experiments. Furthermore, transgenic technology
offers exciting possibilities for generating animal models that
closely mimic human genetic diseases.
Fish, with their external development of transparent
embryos, are excellent candidates for the production of
transgenics because they represent the largest and most
diverse group of vertebrates and provide an ideal system for
in vivo studies of developmental processes that take place
during embryology. Two teleost fish species, namely medaka
(Oryzias latipes) and zebrafish (Danio rerio), represent the
most advanced fish model systems today. Despite many
similarities, the evolutionary distance between medaka and
zebrafish and their last common ancestor, about 160
million years ago, is reflected in many aspects of their
biology. These species provide ideal resources for
comparative studies, allowing the identification of
conserved and species-specific molecular mechanisms that
underlie development and evolution.
Both model organisms are similarly amenable to
transgenesis protocols, which can be broadly classified as
viral and nonviral. Pseudotyped retrovirus infection has
been used to generate single copy insertions of transgenes
[1-3]. Present protocols using this approach are highly
efficient at insertional mutagenesis and enhancer trapping
[4] (Ellingsen S, Wittbrodt J, unpublished data). However,
the construction, packaging, titering, and infection are
laborious processes that require considerable expertise and
safety precautions. Investigators in small laboratories who
intend to generate only few transgenic fish may therefore
wish to use simpler approaches. Nonviral technologies
include a variety of different approaches, such as electro-
poration, particle bombardment, liposomes, stem cell
transfection, nuclear transfer, and microinjection [5-19]. At
present, microinjection provides the fastest and simplestmeans for germline transgenesis and transient expression
studies in fish [20-26].
Here, we review two recently developed approaches to
transgenesis in medaka that significantly enhance the
potential of DNA microinjection. Both strategies are based
on the use of enzymes that bind to DNA, mediate entry into
the nucleus, and facilitate early integration of foreign DNA
into the host genome. In combination with regulatory
sequences or insulators, both techniques also guarantee
stable transgene expression in subsequent generations. One
technique involves the co-injection of the meganuclease I-
SceI [22,23], whereas the second is based on the Sleeping
Beauty transposon [27-29]. The successful application of the
endogenous medaka Tol2 transposon system in zebrafish is
the topic of another detailed review included in this supple-
ment [30]. In addition, a good comparison of Sleeping
Beauty and Tol2 has been published elsewhere [31].
I-SceI meganuclease mediated transgenesis
I-SceI is a homing endonuclease that is encoded by the
mobile group I intron of the large rRNA gene of
Saccharomyces cerevisiae [32,33]. This family of enzymes
mediates the propagation of the intron by cutting intronless
genes at the site of the intron insertion. Like restriction
enzymes, homing endonucleases cleave double-stranded
DNA with high specificity in the presence of divalent metal
ions. However, they differ from restriction endonucleases in
their recognition properties and structures, as well as in
their genomic location [34]. In particular, whereas restric-
tion enzymes have short recognition sequences (3 to 8 base
pairs [bp]), homing endonucleases, despite their small size,
recognize long DNA sequences (12 to 40 bp). They have been
classified into four families based on both their sequence
motifs and DNA cleavage mechanism [35].
The protein I-SceI is a member of the largest class of homing
enzymes, characterized by the presence of either one or two
conserved amino acid residue sequence motifs (LAGLIDADG).
I-SceI acts as a monomeric endonuclease of 235 amino
acids, containing two conserved motifs [36]. Its catalytic
activity depends on the presence of magnesium or
manganese. Cleavage of its recognition sequence (TAGGGA-
TAACAGGGTAAT) results in a 4 bp overhang presenting a
3’-hydroxyl terminus [36]. The enzyme exhibits low turnover
because of a strong affinity for one of the products of the
cleavage reaction [37]. The recently resolved crystal
structure of I-SceI bound to DNA attributes the high
sequence specificity of I-SceI for its recognition sequence to
numerous direct phosphate and base-specific contacts and
water-mediated interactions [38]. Theoretically, an 18 bp
recognition sequence appears once in 70 billion bases of
random sequence. Vertebrate genomes analyzed to date,
including medaka, are free from I-SceI sites, abolishing the
risk for genome fractionation by the meganuclease.
Application of I-SceI in mammalian cells efficiently led to
stably transfected cell lines with single copy integrations
[22]. Based on this, a simple, rapid, and efficient technique
was established in medaka that allows the generation of
stable transgenic lines by co-injection of the I-SceI protein
with reporter vectors that are flanked at both ends by the
corresponding recognition sites (Figure 1). The mega-
nuclease approach has been used successfully in several fish
species (medaka, stickleback, zebrafish), amphibia (axolotl,
Xenopus), and ascidians (Ciona) [39-42]. Compared with
conventional DNA injections, application of the mega-
nuclease protocol increases the number of fish expressing a
transgene in a promoter-dependent manner at 24 hours
postfertilization approximately threefold. In addition, the
level of mosaicism is strongly reduced and stable, promoter-
dependent expression is achieved at up to ten times higher
frequencies in injected embryos at 48 hours postfertilization
[23]. Ultimately, the frequency of resulting transgenic F1
offspring is enhanced by a factor of three compared with
conventional DNA microinjection in fish. Uniform G0
expression in combination with elevated germline trans-
mission frequencies is a good indication for an early
insertion event. Meganuclease transgenesis in medaka
results in germline transmission rates of 25% to 50%, which
- together with enhanced G0 expression - indicate that I-SceI
efficiently facilitates early functional integration of the
transgene (one to two cell stage).
Transgenic fish generated with I-SceI exhibit Mendelian
segregation of transgene expression in F2, indicating that
meganuclease-mediated transgenesis preferentially yields
transgene integration at a single genomic locus. Moreover,
transgenes insert as single copy or as head-to-tail tandem
arrays of low copy number (one to ten) [22]. Thus, the size of
tandem arrays is considerably lower than is observed in
standard plasmid injections (up to 2,000 copies), and
transgene expression has been found to be stable for many
generations [24-26].
How does I-SceI improve transgenesis? During the process
of intron homing, I-SceI creates double strand breaks
(DSBs). Does meganuclease create DSBs simultaneously in
the host genome and the injected plasmid DNA to promote
integration by a repair mechanism? The introduction of
I-SceI mediated DSBs at specific hotspots in the host
genome has not yet been systematically analyzed, but the
existence of multiple endogenous sites is unlikely to occur
because of the length of the recognition sequence (18 bp).
Moreover, this hypothesis is in contrast to the finding of
independent insertion sites in several medaka and Ciona
transgenic lines. Recognition site mutation and deletion
experiments in medaka revealed that nuclear localization
mediated by I-SceI is not sufficient to improve the frequency
of transgenesis. Enhanced frequency of transgenesis
requires cleavage of injected DNA [22]. I-SceI may
counteract endogenous ligase and replicase activity, which is
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of conventionally injected DNA. Thereby, the transgenes
remain as short fragments, exposing more recombinogenic
ends. Through association with one of its cleavage products,
I-SceI may accomplish ‘inhibition’ of endogenous
ligases/replicases by cleavage of generated concatemeres or
by protection of cleaved recombinogenic ends from
degradation/ligation, or both. I-SceI induced DSBs allow
recombination in the mammalian system at high frequency
[43]. Additionally, the natural homing process is thought to
involve the host DSB repair system. Enhanced integration
frequency is initiated by DSBs within the injected DNA and
may involve direct interaction of I-SceI with the DSB repair
machinery. Future experiments to identify interaction
partners of I-SceI will help to elucidate the function of the
meganuclease in transgenesis and to increase its efficiency
further.
Transposon mediated transgenesis
Class II DNA transposable elements are discrete segments of
DNA that are capable of moving from one locus to another in
the host genome or between different genomes. They are
distributed across the living world and play a fundamental
role as motors of genome plasticity. These DNA transposons
contain inverted repeats at either end flanking a central
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Figure 1
Schematic representation of I-SceI vector microinjection. Microinjection for meganuclease mediated transgenesis should be performed as shown.
Embryos should be oriented as indicated. The injection volume must not exceed 10% of the cell volume. (a) An I-SceI vector. The insertion cassette
contains an expression cassette that includes the gene of interest and a reporter cassette. Two insulator sequences and two inverted I-SceI recognition
sites flank the entire insertion cassette. (b) Injection is performed directly into the cytoplasm of the cell. Upon co-injection of DNA with I-SceI, this
procedure will significantly enhance transient transgene expression and frequency of transgenesis. Injection without I-SceI will result in highly mosaic
transient transgene expression and low transgenesis frequency, even if injected into the cytoplasm. (c) Injection into the yolk of a one-cell-stage zebrafish
abolishes the enhancing effect of I-SceI. Transgene expression and transgenesis frequency will be similar to those with conventional microinjection.
Therefore, injection into the yolk only should be avoided. GOI, gene of interest; INS, insulator; P, promoter; pA, polyadenylation signal; REP, reporter
gene. Modified from Grabher and coworkers [23].region encoding a transposase, which catalyzes trans-
position. Transposase-deficient elements can be mobilized if
the transposase is provided in trans by means of an
inducible transposase source or by co-injection of trans-
poson and tranposase mRNA.
Eukaryotic class II transposons move in a nonreplicative
manner via excision and integration (cut and paste). For
transposition, the transposase binds to the inverted repeats
and cleaves the DNA, thereby precisely excising the
transposon. Additionally, the transposase binds to the target
DNA, introducing a staggered cut that leads to protruding
single strands. The DNA repair machinery accomplishes
integration into the host genome, resulting in target site
duplications directly adjacent to the transposon ends.
DNA transposons provide stable gene expression from a
single-copy insertion and simultaneously tag the integration
locus to facilitate subsequent molecular analyses. A variety
of different transposable elements have been utilized
successfully as tools for insertional mutagenesis and gene
delivery in Drosophila [44,45],  Caenorrhabtidis elegans
[46,47], and plants [48]. Until recently, they have not been
used to investigate vertebrate genomes because most
transposon systems that are active in a certain species
cannot simply be transferred to vertebrates because of the
need for species-specific co-factors for transposition.
Moreover, only few well defined autonomous DNA
transposons have been identified in vertebrate species [49].
Tc1/mariner-like transposable elements
Homologs of the Tc1 element in C. elegans and those of the
mariner transposon in Drosophila mauritiana are probably
the most widespread DNA transposons in nature [50].
Tc1/mariner-like elements have been found in many
vertebrate genomes [51-55]. However, unlike Tol2 in
medaka, all of the transposon copies isolated to date are
inactive remnants of once active transposons. Inspired by
the potential for a vertebrate transposon, Ivics and
colleagues [27] engineered a functional Tc1/mariner-like
transposon from inactive copies of several fish species and
named it Sleeping Beauty (SB). The SB transposase has been
shown to mediate transposition efficiently in cells from fish,
mouse, and human in culture [27] and has been used as a
genetic tool in mouse in vivo [56-62]. Within the past few
years, SB has been developed into an efficient gene transfer
tool also in medaka, zebrafish, and Xenopus [28,29,63,64].
Sleeping Beauty
In medaka and zebrafish, the SB transposon system has
been applied successfully to generate transgenic animals by
co-injection of transposon DNA together with transposase
encoding mRNA (Figure 2). Transgenesis frequencies (germ-
line integration and expression in subsequent generations)
were enhanced to more than 30% of the injected embryos,
equaling I-SceI transgenesis rates. Also, the numbers of
embryos that express the transgene in a promoter-
dependent manner in G0 was improved fourfold compared
with control injections in medaka. Using a second
generation SB system, exhibiting improved transposition
efficiency [65], genomic insertions were clearly mediated by
the transposase in zebrafish [29,31]. In medaka, on the other
hand, the original SB system [27] did not prevent
concatemerization of plasmid DNA and resulted in genomic
insertions of plasmid tandem arrays [28]. However, tandem
array insertions also yielded robust and invariable expres-
sion during subsequent generations. Notably, using a
moderate strength ubiquitous promoter to drive GFP
expression led to efficient enhancer trapping, yielding
spatially and temporally restricted transgene expression in
12% of the transgenic medaka. We hypothesize that such
enhancer trap cases result from SB transposase-mediated
transgene insertions to AT-rich scaffold attachment regions
or matrix-attached regions. Such insertion lines provide
useful tools for cell biology, cell lineage, and other
developmental biology applications.
In all SB generated transgenic medaka lines, transgene
expression was stable for more than eight generations,
indicating that even concatemerization of transgenes did not
negatively affect gene expression. This phenomenon is in
accordance with growing evidence suggesting an insulating
activity of inverted repeats, which may account for stabilized
gene expression by shielding from heterochromatin spreading
[66-68]. Most, but not all transgenics yielded insertions at a
single genomic locus. Thus, the SB transposon system
provides flexibility. The transposon/transposase ratio can be
adjusted empirically for robust transgene delivery and
expression at a single genomic locus (trend: high/low) or for
transposase-mediated single copy insertions at multiple loci
(trend: low/high), favorable for insertional mutagenesis and
gene or enhancer trapping (Figure 2).
Perspectives
Similar applications may be envisaged for both mega-
nuclease and transposon mediated transgenesis. Nonethe-
less, because of the different biologic characteristics of the
two technologies, for certain applications one or the other
appears more suitable.
I-SceI meganuclease
The meganuclease may be used in fish for comparative
studies of cis-acting regulatory elements and homologous
recombination.
Direct comparison of regulatory elements is often hampered
by effects on transgene expression mediated by the specific
locus of insertion and/or distribution of episomal plasmid
DNA. A meganuclease site artificially engineered into a host
genome may serve as a unique entrance site for transgene
integration. In lieu of embryonic stem cells contributing to
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introduced by transposon-mediated transgenesis. A suitable
expression locus that is unaffected by the host genomic
environment can then be selected and used for any kind of
transgenesis and in particular to perform comparative
studies on regulatory elements under controlled conditions.
Further improvements in meganuclease transgenesis include
insulators upstream and downstream of the DNA of interest
to protect the transgene from influences of heterochromatin
and epigenetic control of surrounding genomic sequences.
Gene targeting in Drosophila has been attempted by using
heatshock activated I-SceI expression in transgenic flies
[69]. However, use of I-SceI alone failed to yield gene
targeting events, probably because of inefficient I-SceI
activity and a highly efficient repair of chromosomal I-SceI
mediated DSBs. Direct interactions of meganucleases with
components of the host DSB repair are conceivable, because
association of homing endonucleases with DSB repair is
evolutionarily ancient. Indeed, meganuclease-induced DSBs
are not sufficient to promote integration into the genome
because injection of in vitro linearized DNA fragments
resulted in lower transgenesis frequencies than did co-
injections of I-SceI enzyme with DNA [22]. This is indicative
of an additional function performed by the meganuclease.
Enhanced integration frequency may be initiated by DSBs,
and direct interactions of I-SceI with the DSB repair
machinery. The relative abundance of I-SceI enzyme
injected into one-cell-stage fish embryos may compensate
for the low activity observed in transgenic flies; thus, I-SceI
meganuclease could provide a valid approach for gene
targeting in fish.
Sleeping Beauty
The efficiency of SB-mediated gene transfer is inversely
proportional to transposon size [65,70-72]. This is not an
issue for insertional mutagenesis, in which the sole purpose
of the transposon is to inactivate a gene and provide a short
sequence tag for recovery of the insertion. For transgenesis,
however, it is desirable that a transposon vector can mobilize
large genes. Recent advances have been made in the
development of hyperactive SB vectors, including the use of
more efficient repeat sequences, transposases of higher
activity, and application of ‘sandwich’ transposons that allow
mobilization of large transgenes [65,73]. Furthermore, CpG
methylation of the SB transposon enhanced transposition in
mammalian cells 100-fold [74]. It is to be expected that
these improvements in transposition efficacy also hold true
in fish, which will be especially important for applications
that require high insertion rates such as insertional muta-
genesis and enhancer or gene trap experiments.
A major advantage of highly efficient transposon mediated
transgenesis for mutagenesis and trapping experiments is the
possibility to remobilize transposon insertions by classical
breeding of transgenic animals. One transgenic line would
express the transposase, whereas the other would harbor the
transposon to be mobilized. Among vertebrates, such experi-
mental approaches have been successfully applied in mice and
fish [56-59,75-78]. Ideally, the transposon would contain a
gene trap vector (Figure 2) to select directly for transposon
insertions into genes and to reveal their expression pattern.
Adding to the potential of the SB system, another artificially
reconstructed transposon, namely Frog Prince, with high
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Figure 2
SB vector microinjection. (a) Sleeping Beauty (SB) transgenesis vector. The insertion cassette containing an expression cassette that includes the gene of
interest (GOI) and a reporter cassette is flanked by two SB inverted/direct repeats (IRDRs). (b) SB gene trap vector containing a splice acceptor site
preceding a reporter gene. (c) SB enhancer trap vector. A minimal promoter drives expression of a reporter gene. SB vectors are co-injected with SB
mRNA into one-cell-stage embryos. MP, minimal promoter; P, promoter; pA, polyadenylation signal; REP, reporter gene; SA, splice acceptor site.transpositional activity in vertebrate cells has been described
[79]. Pilot experiments in medaka confirmed the activity of
Frog Prince in fish embryos (Wittbrodt J, unpublished data),
providing the community with yet another promising tool.
Conclusion
In recent years, meganuclease and transposon mediated
transgenesis protocols had a major impact on research
employing transgenic animals, in particular, fish and lower
vertebrates but also mice. The relative ease of their
application and the flexibility of both of these systems
ensured their wide distribution and popular use. Owing to
certain inherently different characteristics of these two
approaches, further development of either system will
probably result in more efficient and specialized
applications. More advanced knowledge on the function of
transposons has already generated the next generation of
tools such as Frog Prince and Tol2. It will be interesting to
see whether further insights into the mode of action of the
meganuclease in transgenesis can contribute to standardized
transgenic animals or a means to homologous recombination
in medaka.
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